Pricing

Hillevax

2 followers

‌

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Their initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infecti... Read more

Industries

Headquarters

Boston, United States

Employees

Links

Org chart

CEO, President & Chair

Rob Hershberg

Collapse

COO

Chief Financial Officer

Astrid Borkowski

Chief Medical Officer

General Counsel, Secretary & Chief Administrative Officer

Director, Strategy And Operations, Chief Medical Office

Senior Vice President

Christopher Aakre, PhD

Vice President, Program Management

VP Analytical Research & Development

Vice President, Head Of Clinical Assays

Vice President Of Quality

Chief Technology Officer

VP, Head of Clinical Operations

Director, Research & Pre-clinical Development

Teams

Directors Team

10 members

Research and Development

4 members

Leadership Team

5 members

Accounting and Finance

4 members

Quality Assurance and Compliance

1 members

Vice Presidents

4 members

Similar companies

Elicio Therapeutics

1 follower

Artiva Biotherapeutics

1 follower

ByHeart

2 followers

Cytokinetics

11 followers

Capricor Therapeutics

1 follower

Neurocrine Biosciences

5 followers

Coherus BioSciences

5 followers

4D Molecular Therapeutics

3 followers

KIA

2 followers

The Cumulus Coffee Company

2 followers

Axsome Therapeutics

2 followers

Explore companies